I. Sahin Et Al. , "BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?," JOURNAL OF BUON , vol.16, no.1, pp.184-185, 2011
Sahin, I. Et Al. 2011. BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?. JOURNAL OF BUON , vol.16, no.1 , 184-185.
Sahin, I., Ararat, E., & Altundag, K., (2011). BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?. JOURNAL OF BUON , vol.16, no.1, 184-185.
Sahin, I., E. Ararat, And K. Altundag. "BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?," JOURNAL OF BUON , vol.16, no.1, 184-185, 2011
Sahin, I. Et Al. "BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?." JOURNAL OF BUON , vol.16, no.1, pp.184-185, 2011
Sahin, I. Ararat, E. And Altundag, K. (2011) . "BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?." JOURNAL OF BUON , vol.16, no.1, pp.184-185.
@article{article, author={I. Sahin Et Al. }, title={BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?}, journal={JOURNAL OF BUON}, year=2011, pages={184-185} }